MedPath

Study of Koflet in Cough

Phase 2
Conditions
Health Condition 1: J069- Acute upper respiratory infection,unspecified
Registration Number
CTRI/2023/01/049070
Lead Sponsor
Himalaya Wellness Company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subjects presenting with primary acute common cold symptoms like cough and sore throat.

Subjects presenting with associated secondary symptoms like chest congestion, sneezing, running nose.

Subjects willing to sign informed consent and follow the study procedure.

Subjects who have not participated in similar kind of investigation in past 4 weeks.

Exclusion Criteria

Subjects with clinically significant serious cardiovascular cerebrovascular, respiratory, hepatic, renal disease, congenital or any other disorder.

Subjects with a VAS Score more than 7.

Subjects suffering from accompanying illnesses such as bronchiolitis, pneumonia, pleuritis, septic infections, and other chronic respiratory disorder especially upper respiratory tract infection with complications.

A known history or present condition of allergic response to pharmaceutical products its components or ingredients in the test product.

Subjects on any medication that would affect the evaluation like anti histamines, steroids, OTC, or any other herbal medicines for the control of URTI symptoms.

Pre-existing systemic disease necessitating long-term medications.

Genetic and endocrinal disorders.

Any history of seasonal or perennial allergic rhinitis.

Pregnant and lactating women

Subjects addicted to smoking, tobacco/ pan masala chewing or alcohol.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath